BriaCell Therapeutics Corp.
BCTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001610820
No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.58M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in BriaCell Therapeutics Corp. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- 0 vs. Q4 2022
- Shares held
- 2.60M
- −61.3K (−2.3%) vs. Q4 2022
- Total value
- $19.4M
- +$7.08M (+57.6%) vs. Q4 2022
- New holders
- 5
- 5 more added
- Sold out
- 5
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $1.58M |
| Q1 2026 | 16 | $1.62M |
| Q4 2025 | 13 | $69.2K |
| Q3 2025 | 13 | $136.5K |
| Q2 2025 | 16 | $181.1K |
| Q1 2025 | 14 | $94.1K |
| Q4 2024 | 26 | $379.1K |
| Q3 2024 | 22 | $538.1K |
| Q2 2024 | 20 | $452.0K |
| Q1 2024 | 20 | $6.38M |
| Q4 2023 | 26 | $14.6M |
| Q3 2023 | 21 | $17.0M |
| Q2 2023 | 21 | $17.9M |
| Q1 2023 | 21 | $19.4M |
| Q4 2022 | 21 | $12.3M |
| Q3 2022 | 22 | $14.3M |
| Q2 2022 | 22 | $17.0M |
| Q1 2022 | 18 | $33.5M |
| Q4 2021 | 20 | $10.9M |
| Q3 2021 | 21 | $4.77M |
| Q2 2021 | 24 | $20.3M |
| Q1 2021 | 10 | $1.45M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding BriaCell Therapeutics Corp.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynwood Capital Management Inc. | 1,530,000 | $11.4M | 16.93% | 00.0% | Unchanged |
| Wasatch Advisors Inc | 616,078 | $4.59M | 0.03% | +209,468+51.5% | Added |
| Redmond Asset Management, LLC | 137,689 | $1.03M | 0.35% | 00.0% | Unchanged |
| K.J. Harrison & Partners Inc | 105,933 | $785.1K | 0.16% | −321,650−75.2% | Reduced |
| Morgan Stanley | 70,737 | $527.0K | 0.00% | +66,813+1,702.7% | Added |
| Summit Trail Advisors, LLC | 35,000 | $260.8K | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 30,670 | $228.5K | 0.00% | +30,670 | New |
| Bank of Montreal | 25,146 | $186.6K | 0.00% | +14,646+139.5% | Added |
| Concord Wealth Partners | 17,775 | $132.4K | 0.04% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 14,350 | $107.0K | 0.00% | +14,350 | New |
| XTX Topco Ltd | 10,383 | $77.4K | 0.02% | +10,383 | New |
| Tower Research Capital LLC (TRC) | 4,187 | $31.0K | 0.00% | +627+17.6% | Added |
| National Bank of Canada | 2,500 | $18.4K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,044 | $7.00K | 0.00% | −27,852−96.4% | Reduced |
| Advisory Services Network, LLC | 650 | $4.84K | 0.00% | −527−44.8% | Reduced |
| Bank of America Corp | 277 | $2.06K | 0.00% | +165+147.3% | Added |
| UBS Group AG | 169 | $1.26K | 0.00% | +169 | New |
| GHP Investment Advisors, Inc. | 33 | $246 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 32 | $238 | 0.00% | 00.0% | Unchanged |
| Belpointe Asset Management LLC | 15 | $108 | 0.00% | +15 | New |
| Rosenberg Matthew Hamilton | 12 | $89 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,263−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,773−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −11,905−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −177−100.0% | Sold out |